Epidemiology and Control of Mansonella Perstans Infection in Uganda

NCT00215280 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2007-04-20

No results posted yet for this study

Summary

Mansonella perstans (M. perstans) infection is widespread in Uganda. Knowledge about the epidemiology of this infection, and of the morbidity it induces is poor, and no effective treatment is available. The study aims at providing data on diagnostic, epidemiological, morbidity and treatment aspects of M. perstans infections in Uganda.

Conditions

  • Mansonelliasis
  • Pruritus
  • Lymphoedema
  • Abdominal Pains

Interventions

DRUG

ivermectin and albendazole

Sponsors & Collaborators

  • Ministry of Health, Uganda

    collaborator OTHER_GOV
  • DBL -Institute for Health Research and Development

    lead OTHER

Principal Investigators

  • Asanta M Asio, Msc · Ministry of Health, Uganda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Completion
2006-02-28

Countries

  • Uganda

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00215280 on ClinicalTrials.gov